Research Briefs

Date of this Version

4-1-2016

Abstract

Medicare Part D beneficiaries with higher out-of-pocket costs are more likely to delay starting or not start a recommended specialty drug when newly diagnosed with leukemia. Policy changes are needed to ensure optimal access to specialty medications under Medicare Part D.

Document Type

Brief

Number

13

License

Creative Commons License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 License.

Keywords

health insurance, medicare

View On LDI Website

http://ldi.upenn.edu/brief/high-cost-sharing-and-specialty-drug-initiation-under-medicare-part-d-case-study-patients

Share

COinS
 

Date Posted: 09 December 2016